Kos Pharmaceuticals is Pharmaceuticals in United States that focus on calcium channel blocker business. Founded in 1988. They cover business area such as manufacturer, prescription product, chronic cardiovascular disease, treatment, primary hypercholesterolemia, mixed dyslipidemia, mixed lipid disorder, nondihydropyridine calcium channel blocker, doctor, hypertension, stable angina.
1988
( 36 years old in 2024 )
Calcium Channel Blocker
-
1001 Brickell Bay Drive
25th Floor
Miami, FL 33131
United States
Private
manufacturerprescription productchronic cardiovascular diseasetreatmentprimary hypercholesterolemiamixed dyslipidemiamixed lipid disordernondihydropyridine calcium channel blockerdoctorhypertensionstable angina
* We use standard office opening hours in near Kos Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Kos Pharmaceuticals is Pharmaceuticals business from United States that founded in 1988 (36 years old in 2024), Kos Pharmaceuticals business is focusing on Calcium Channel Blocker.
Kos Pharmaceuticals headquarter office and corporate office address is located in 1001 Brickell Bay Drive 25th Floor Miami, FL 33131 United States.
Kos Pharmaceuticals was founded in United States.
In 2024, Kos Pharmaceuticals is currently focus on calcium channel blocker sector.
Above is snippet of Google Trends for "calcium channel blocker" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Kos Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
